← Back to headlines
Pfizer's GLP-1 Therapy Shows Promise for Monthly Dosing in Mid-Stage Trial
Pfizer announced that mid-stage trial data supports monthly dosing for its GLP-1 therapy, indicating potential for a new treatment option.
6 Jun, 14:09 — 6 Jun, 14:09
Sources
Showing 1 of 1 sources
